Does Rallies show Form 4 insider transactions for XLO?

Yes. Rallies tracks XLO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is XLO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.

XLO (Xilio Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XLO stock inside the company?

Recent XLO insider activity includes Shannon James Samuel bought 5.00K, Brennan Kevin M. sold 1.83K, Frankenfield Christopher James sold 7.03K, Shannon James Samuel bought 25.00K, and Shannon James Samuel bought 45.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

XLO Key Metrics

Key financial metrics for XLO
Metric	Value
Price	$8.44
Market Cap	$48.76M
P/E Ratio	-1.97
EPS	$-4.19
Dividend Yield	0.00%
52-Week High	$23.80
52-Week Low	$6.47
Volume	0
Avg Volume	0
Revenue (TTM)	$43.77M
Net Income	$-35.04M
Gross Margin	0.00%

Recent XLO Insider Trades

Shannon James Samuel bought 5.00K (~$43.95K) on Mar 26, 2026.
Brennan Kevin M. sold 1.83K (~$1.17K) on Jan 2, 2026.
Frankenfield Christopher James sold 7.03K (~$4.52K) on Jan 2, 2026.
Shannon James Samuel bought 25.00K (~$17.21K) on Jun 17, 2025.
Shannon James Samuel bought 45.00K (~$30.87K) on Jun 16, 2025.

Latest XLO News

Xilio Therapeutics Extends Runway to 2028, Plans XTX501 IND in Mid-2026 — May 12, 2026
Xilio Therapeutics Plans 1-for-14 Reverse Split to Cut Shares to 5.2M — Mar 12, 2026
Xilio Therapeutics Raises $40M with 74.8M Pre-Funded Warrants at $0.5349 — Feb 12, 2026

XLO Analyst Consensus

XLO analyst coverage data. Average price target: $0.00.

Common questions about XLO

Who is trading XLO stock inside the company?: Recent XLO insider activity includes Shannon James Samuel bought 5.00K, Brennan Kevin M. sold 1.83K, Frankenfield Christopher James sold 7.03K, Shannon James Samuel bought 25.00K, and Shannon James Samuel bought 45.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for XLO?: Yes. Rallies tracks XLO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XLO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.